Substituted carbamoylmethylamino acetic acid derivatives as novel NEP inhibitors

Details for Australian Patent Application No. 2010320930 (hide)

Owner Novartis AG

Inventors Iwaki, Yuki; Kawanami, Toshio; Ksander, Gary Michael; Mogi, Muneto

Agent Davies Collison Cave

Pub. Number AU-A-2010320930

PCT Pub. Number WO2011/061271

Priority 61/359,914 30.06.10 US; 61/263,137 20.11.09 US

Filing date 18 November 2010

Wipo publication date 26 May 2011

International Classifications

C07D 231/40 (2006.01) Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings

A61K 31/41 (2006.01) - having five-membered rings with two or more ring hetero atoms, at least one of which is nitrogen, e.g. tetrazole

A61K 31/415 (2006.01) - 1,2-Diazoles

A61K 31/42 (2006.01) - Oxazoles

A61P 7/10 (2006.01) Drugs for disorders of the blood or the extracellular fluid

C07D 257/06 (2006.01) Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms

C07D 261/14 (2006.01) Heterocyclic compounds having nitrogen and oxygen as the only ring hetero atoms

Event Publications

12 April 2012 PCT application entered the National Phase

  PCT publication WO2011/061271 Priority application(s): WO2011/061271

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010320932-Mounting system and method for mounting a dividing wall on a holding device, and device for dividing regions

2010320925-Kit for producing a stair case